| 1 | Technology | XLK | +28.1% |
| 2 | Energy | XLE | +26.1% |
| 3 | Materials | XLB | +13.1% |
| 4 | Real Estate | XLRE | +12.3% |
| 5 | Industrials | XLI | +11.5% |
| 6 | Consumer Staples | XLP | +10.5% |
| 7 | Utilities | XLU | +3.1% |
| 8 | Healthcare | XLV | -1.1% |
| 9 | Consumer Disc. | XLY | -1.5% |
| 10 | Financials | XLF | -2.9% |
| 11 | Communication | XLC | -4.5% |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q1 '26 | 5/1/26 | $-3.71 | $-1.18 | +68.2% | +53% | $0.2B | $0.4B | +66.4% | +260% |
| Q4 '25 | 2/13/26 | $-2.60 | $-2.11 | +18.9% | +27% | $0.6B | $0.7B | +6.1% | -30% |
| Q3 '25 | 11/6/25 | $-2.17 | $-0.51 | +76.5% | -1800% | $0.9B | $1.0B | +17.3% | -45% |
| Q2 '25 | 8/1/25 | $-2.98 | $-2.13 | +28.5% | +36% | $0.1B | $0.1B | +19.3% | -41% |
| Q1 '25 | 5/1/25 | $-3.18 | $-2.52 | +20.8% | +18% | $0.1B | $0.1B | -6.3% | -35% |